Therefore, targeting key enzymes involved in DNA DSB repair, particularly the protein kinases ATM, ATR and DNA-Pkcs, in relatively radioresistant HPV-negative HNSCC that are DSB repair-proficient is considered to be an approach to sensitise these tumours to radiotherapy. The gene discussed is ATM; the disease is neoplasm.